LDOS · Leidos Holdings, Inc.

Track LDOS — free

$146.31 +2.83 (+1.97%) At close · Aug 19

Market Cap

$18.36B

125.49M

Up next

Next earnings call

Nov 3, 2026 Est · unconfirmed · in 11 wks

FQ3-27 quarter ends

~Oct 1, 2026 Est

Latest filing: 10-Q

filed Aug 4, 2026

AI Brief

TL;DR.

Bullish

Bearish

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Ask ALVIS about this →

Equibles Rating

blended score · not investment advice

Overall

Neutral

SellHoldBuy

Technical Neutral Momentum Weak Sentiment Neutral Fundamentals Strong Quant / Vol High

Market backdrop VIX 14.9 · calm Equity put/call 0.52

Technical

price trend

Neutral

50 / 200-day cross No cross

Price vs 200-day avg −7%

below

Price vs 50-day avg +25%

above

RSI (14) 77

overbought

MACD trend Positive

52-week position 47%

mid-range

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Weak

1-month return +36%

trailing

6-month return −17%

trailing

YTD return −19%

this year

Relative strength −28%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $117 › 200d $157 — 200d above 50d

Institutional flow Distributing

-15% holders QoQ · +81 funds added

Insider flow Distributing

Net -$1.4M over 90 days · 100% sells

Short interest Falling

4.14% of float · ▼ -18.9% MoM · 3.7 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

765 holders — mid 3-yr range

Squeeze score 59

elevated · 0–100

Fundamentals

Strong

Revenue growth +3%

Y/Y

EPS growth +21%

Y/Y

Free cash flow $1.6B

Valuation P/E 13.6

below peers

Balance sheet $3.6B

net debt

Quant / Vol

risk profile

High

Volatility 34%

annualized · 1-yr

Max drawdown −50%

past year

ATR 3.0%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Latest guidance · from the 8-K filed Aug 4, 2026

Adjusted EBITDA Margin · FY26 Non-GAAP Initiated 13%

Non-GAAP Diluted EPS · FY26 Non-GAAP Initiated $12.20 – $12.50

Prior guidance period ended · from the 8-K filed Nov 4, 2025

Non-GAAP Diluted EPS · FY25 $11.45 – $11.75

Guided vs delivered · last 1 settled

Revenue guidance 2024

guided $16.35B – $16.45B

guided $16.35B – $16.45B $16.66B Beat +1.6%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral

2 · 3 · 2

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

−7% Bearish

Price vs 50-day avg

+25% Bullish

RSI (14)

77 Bearish

MACD trend

Positive Bullish

52-week position

47% Neutral

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Bearish · 2 of 6

Trend (MA cross) No cross

50d $117 › 200d $157 — 200d above 50d

Institutional flow Distributing

-15% holders QoQ · +81 funds added

Insider flow Distributing

Net -$1.4M over 90 days · 100% sells

Short interest Falling

4.14% of float · ▼ -18.9% MoM · 3.7 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

765 holders — mid 3-yr range

Price context

position in its 52-week range

Range low $100 Now $146 · 47% Range high $200

vs 200-day avg -7% vs 50-day avg +25%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings

Metric	Latest	Period	YoY
Adjusted EBITDA non-GAAP	$1.25B	Six Months Ended July 3, 2026	—

Adjusted EBITDA margin non-GAAP	13.9%	Six Months Ended July 3, 2026	—

Backlog	48.7B	Three Months Ended July 3, 2026	—
Book-to-bill ratio	1.1	Three Months Ended July 3, 2026	—
Defense backlog	$13.76B	July 3, 2026	—
Defense non-GAAP operating margin non-GAAP	9.9%	Q2 FY2026	—
Free cash flow conversion ratio non-GAAP	185%	Three Months Ended July 3, 2026	—
Funded backlog	10.2B	Three Months Ended July 3, 2026	—
Health backlog	$6.61B	July 3, 2026	—
Health non-GAAP operating margin non-GAAP	23.8%	Q2 FY2026	—
Homeland backlog	$9.93B	July 3, 2026	—
Homeland non-GAAP operating margin non-GAAP	12.1%	Q2 FY2026	—
Intelligence & Digital backlog	$18.41B	July 3, 2026	—
Intelligence & Digital non-GAAP operating margin non-GAAP	10.1%	Q2 FY2026	—
Net bookings	4.9B	Three Months Ended July 3, 2026	—
Non-GAAP Free Cash Flow non-GAAP	$761M	Three Months Ended July 3, 2026	—

Non-GAAP operating margin non-GAAP	12.8%	Q2 FY2026	—
Operating cash flow conversion ratio	224%	Three Months Ended July 3, 2026	—
Organic revenues non-GAAP	$4.41B	Q2 FY2026	—
GAAP → non-GAAP reconciliation GAAP Revenues, as reported 4.56B -150M Acquisition and divestiture revenues = Organic revenues 4.41B
Trailing-twelve-month book-to-bill	1.1	Three Months Ended July 3, 2026	—
Unfunded backlog	$38.49B	July 3, 2026	—
Free cash flow non-GAAP	$1.63B	Year Ended January 2, 2026	—
Free cash flow conversion non-GAAP	104%	Year Ended January 2, 2026	—

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Information Technology Services — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
LDOS Leidos Holdings, Inc. this stock	$18.36B	-18.9%	+3.1%	13.6	4.1%
IBM International Business Machines Corp	$223.44B	-19.9%	+7.6%	21.0	2.4%
ACN Accenture plc	$115.48B	-31.7%	+7.4%	13.8	4.9%
INFY Infosys Ltd	$48.72B	-32.5%	—	—	3.6%
CTSH Cognizant Technology Solutions Corp	$29.09B	-26.6%	+7.0%	13.3	9.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

765

% held: 79.9%
Net QoQ: +3.3M sh
Top holder: BlackRock, Inc.

Held Float

View

Held by Funds

Fund positions

786

View

Short & Settlement

Short Interest Falling

Shares short

5.2M

Days to cover: 3.7d
Change: -1.2M sh

View

Short Volume

Short vol %

46%

As of: Aug 19, 2026

Short Total

View

Fails to Deliver

FTD shares

5.1K

Value: $591.6K
As of: Jul 28, 2026

View

Off-Exchange

Off-exchange %

46.5%

Week of: Jul 13, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$1.4M

Buyers / Sellers: 0 / 1

Buyers Sellers

View

Congressional Trades Sell

Member

Alan Armstrong

Amount: $15.0K–$50.0K
Traded: Mar 27, 2026

View

Financials

Revenue (FY)

$17.2B

Net income (FY): $1.4B
EPS diluted: $11.14

View

Buybacks

Authorized

shares 40.0M

View

Filings

SEC Filings

Latest

8-K

Filed: Aug 4, 2026
This year: 13

View

Proposed Sales

Value

$1.4M

Shares: 10.0K
Filed: Aug 11, 2026

View

Earnings & Events

Earnings Calls

Last call

Aug 4, 2026

View

Performance

	5D	20D	120D	MTD	YTD
LDOS	+4.2%	+36.4%	-16.8%	+26.6%	-18.9%
SPY	-0.4%	+2.9%	+11.6%	+3.0%	+12.8%
vs SPY	+4.7%	+33.5%	-28.4%	+23.6%	-31.7%

Capital returns

Latest dividend

$0.43 / share · ex Jun 15, 2026

Declared · upcoming

$0.43 / share · ex Sep 15, 2026

Raised 7.5%

Paid (TTM)

$1.69 / share · 4 payouts

Dividend yield (TTM, derived)

1.16%

Buyback program · as of Jan 31, 2012

Authorized

shares 40.00M

Spent (derived)

—

Remaining

—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1336920 CUSIP 525327102 13F (30d) 659 filings 653 filers Visit website Investor relations

LDOS · Leidos Holdings, Inc.

Price & Indicators

Up next

AI Brief

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance

Capital returns